Savara, Inc. (SVRA)

5.075 +0.14 (+2.94%) USD  |  NASDAQ  |  Jun 10, 14:41
More

Savara EBITDA Margin (TTM)

EBITDA Margin (TTM) Chart

View EBITDA Margin (TTM) for SVRA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EBITDA Margin (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EBITDA Margin (TTM) Range, Past 5 Years

View EBITDA Margin (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EBITDA Margin (TTM) Benchmarks

View EBITDA Margin (TTM) Benchmarks
Start Trial
Marker Therapeutics, Inc. Upgrade
SELLAS Life Sciences Group, Inc. --
Viridian Therapeutics, Inc. Upgrade
KalVista Pharmaceuticals, Inc. --
Spyre Therapeutics, Inc. --